Mortality Outcomes Related to Multi-drug Resistant Organisms in Cystic Fibrosis Lung Transplant Recipients: An International Society of Heart and Lung Transplantation (ISHLT) Registry Study

Patients with cystic fibrosis (CF) may have pulmonary infection with multi-drug resistant organisms (MDRO) potentially impacting post-transplant mortality. Our objective was to study 1-year mortality in CF patients with MDRO compared to those without MDRO lung transplant recipients (LTR) querying the largest international registry.

Source: The Journal of Heart and Lung Transplantation - March 31, 2018 Category: Transplant Surgery Authors: C. Lay, N. Law, A.M. Holm, C. Benden, S. Aslam Source Type: research